Personalized follow-up plans for people diagnosed with colorectal cancer before age 50
Risk stratified survivorship care pathways for early-onset colorectal cancer
This project will create tailored follow-up and support plans that match surveillance and services to the recurrence risk and needs of people diagnosed with colorectal cancer under 50.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11285286 on NIH RePORTER |
What this research studies
We will work with cancer registries in Georgia, Kentucky, and Los Angeles County to study patterns of cancer coming back among people diagnosed with stage I-III colorectal cancer before age 50. Using a new method, researchers will estimate how likely recurrence is for different groups and gather information about survivors’ medical, financial, and emotional needs. That information will be used to design risk-stratified care pathways that match how closely someone needs to be watched and what support services they should receive. The goal is more useful, fair, and easier-to-navigate survivorship care for younger colorectal cancer survivors.
Who could benefit from this research
Good fit: Adults diagnosed with stage I-III colorectal cancer before age 50, especially survivors residing in the participating regions, are the primary group this work focuses on.
Not a fit: People with stage IV disease, those diagnosed at age 50 or older, or patients living outside the studied regions are less likely to directly benefit from these findings.
Why it matters
Potential benefit: If successful, this work could lead to follow-up schedules and support services that better match each younger survivor’s risk and needs, reducing unnecessary testing and improving access to help.
How similar studies have performed: Risk-stratified follow-up has been used in other cancers, but applying population-level recurrence estimates and tailored pathways specifically to early-onset colorectal cancer is largely new.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Wallner, Lauren P — University of Michigan at Ann Arbor
- Study coordinator: Wallner, Lauren P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.